hengrui glp-1 has submitted an IND application for HRS5931 in China Hengrui Pharma and Kailera Therapeutics

He practices in Bountiful, Utah at Cope Family Medicine and is accepting new patients for weight loss and metabolic health consultations

The platform has been operating since 2017 and has treated millions of patients

Quantitative appetite assessments using validated scales demonstrate significant reductions in hunger scores and increases in fullness ratings compared to baseline

Conditions such as irritable bowel syndrome (IBS) exemplify this mind-gut interaction

Results May Vary: Individual results will vary based on factors including age, baseline health condition, lifestyle factors, consistency of use, genetic factors, current medications, diet, exercise habits, and other individual variables